ClinicalTrials.Veeva

Menu

Performance of a New Glucose Meter System

Ascensia Diabetes Care logo

Ascensia Diabetes Care

Status

Completed

Conditions

Diabetes

Treatments

Device: Investigational Blood Glucose Monitoring System

Study type

Interventional

Funder types

Industry

Identifiers

NCT01264016
CTD-2010-004-01

Details and patient eligibility

About

The purpose of this study is to evaluate the performance and acceptability of a new blood glucose monitoring system, which includes meter and sensor strip.

Enrollment

96 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Type 1 or 2 diabetes
  • Age 18 years or older
  • Routinely performs blood glucose self testing at home, at least once per day
  • Able to speak, read, and understand English.
  • Is willing to complete all study procedures

Exclusion criteria

  • Currently pregnant
  • Hemophilia or any other bleeding disorder
  • Taking prescription anticoagulants or has clotting problems that may prolong bleeding. Taking aspirin daily is not excluded
  • Subject employee of competitive medical device company
  • Cognitive disorder or other condition, which in the opinion of the investigator, would put the person at risk or seriously compromise the integrity of the study

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

96 participants in 1 patient group

Intended Users of the Monitoring System
Experimental group
Description:
Untrained subjects with diabetes use an investigational blood glucose monitoring system.
Treatment:
Device: Investigational Blood Glucose Monitoring System

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems